Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 20, 2026 16:55 ET | Source: Robbins LLP

OST Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Securities Fraud Class Action Against Ostin Technology Group Co., Ltd.

Robbins LLP is Investigating Allegations that Ostin Technology Group Co., Ltd. (OST) Engaged in a Pump-and-Dump Scheme that Defrauded Investors
February 20, 2026 16:38 ET | Source: Robbins LLP

ENPH Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Enphase Energy, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Enphase Energy, Inc. (ENPH) Misled Investors Regarding its Ability to Manage its Channel Inventory
February 18, 2026 14:11 ET | Source: Robbins LLP

Stockholders Who Lost Money Investing in Mereo BioPharma Group plc Should Contact Robbins LLP for Information About Recovering Their Losses from MREO

Robbins LLP is Investigating Allegations that Mereo BioPharma Group plc (MREO) Misled Investors Regarding Phase 3 Orbit and Cosmic Studies for Setrusumab
February 18, 2026 14:07 ET | Source: Robbins LLP

Stockholders Who Lost Money Investing in Ultragenyx Pharmaceutical Inc. Should Contact Robbins LLP for Information About Recovering Their Losses from RARE

Robbins LLP is Investigating Allegations that Ultragenyx Pharmaceutical Inc. (RARE) Misled Investors Regarding Phase III Orbit and Cosmic Studies
February 18, 2026 13:44 ET | Source: Robbins LLP

Stockholders Who Lost Money Investing in Oracle Corporation Should Contact Robbins LLP for Information About Recovering Their Losses from ORCL

Robbins LLP is Investigating Allegations that Oracle Corporation (ORCL) Misled Investors Regarding its Data Center Capabilities for AI Infrastructure
February 17, 2026 14:29 ET | Source: Robbins LLP

Robbins LLP Urges AGL Stockholders with Large Losses to Contact the Firm for Information About Leading the Agilon Health, Inc. Securities Class Action

Robbins LLP is Investigating Allegations that Agilon Health, Inc. (AGL) Misled Investors Regarding its Business Prospects
February 16, 2026 20:24 ET | Source: Robbins LLP

KD Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Kyndryl Holdings, Inc. Class Action

Robbins LLP is Investigating Allegations that Kyndryl Holdings, Inc. (KD) Materially Misstated its Financial Statements
February 13, 2026 14:56 ET | Source: Robbins LLP

INO Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Inovio Pharmaceuticals, Inc. Class Action

Robbins LLP is Investigating Allegations that Inovio Pharmaceuticals, Inc. (INO) Misled Investors Regarding Approval for its CELLECTRA Device
February 13, 2026 13:17 ET | Source: Robbins LLP

VTGN Investors with Large Losses Should Contact Robbins LLP for Information About Leading the Vistagen Therapeutics, Inc. Class Action

Robbins LLP is Investigating Allegations that Vistagen Therapeutics, Inc. (VTGN) Misled Investors Regarding the Viability of its Trial Study of Fasedieno
February 13, 2026 13:04 ET | Source: Robbins LLP

FRMI Investors with Large Losses Should Contact Robbins LLP for Information About Leading the Fermi Inc. Class Action

Robbins LLP is Investigating Allegations that Fermi Inc. (FRMI) Misled Investors Regarding its Business Prospects